The disclosure generally relates to systems and methods for the introduction of chemical or biological agents into living cells or cell particles or lipid vesicles.
There exists a need for improved systems and methods for systems and methods for electroporation, as disclosed herein.
Embodiments of the present disclosure provide a processing assembly configured for use in an electroporation system. The processing assembly may include a housing, a lid connected to the housing, an opening in a top surface of the housing, an electroporation chamber below the opening of the housing, wherein the electroporation chamber comprises (i) a gasket forming the shape of the electroporation chamber and defining the volume of one or more wells within the electroporation chamber, and (ii) two or more electrodes comprising an electrically conductive, non-cytotoxic metal, wherein the two or more electrodes are positioned on opposing sides of the electroporation chamber, and wherein the processing assembly further comprises two or more buses, each connected to a single electrode.
Embodiments of the present disclosure may provide a multi-well processing assembly configured for use in an electroporation system. The multi-well processing assembly may include a housing, a lid rotationally connectable to the housing, an opening in a top surface of the housing, an electroporation chamber below the opening of the housing, wherein the electroporation chamber comprises (i) a gasket forming the shape of the electroporation chamber and defining the volume of one or more wells within the electroporation chamber, and (ii) two or more electrodes comprising an electrically conductive, non-cytotoxic metal, wherein the two or more electrodes are positioned on opposing sides of the electroporation chamber, and wherein the multi-well processing assembly further comprises two or more buses, each connected to a single electrode.
Embodiments of the present disclosure may provide a docking station configured for use in an electroporation system. The docking station may include a housing, a port in the housing configured to receive one or more processing assemblies, a lid connected to the housing, and one or more contacts configured to connect the docking station to an electroporation system.
Embodiments of the present disclosure may provide an electroporation system that includes a processing assembly configured for use in an electroporation system. The processing assembly may include a housing, a lid connected to the housing, an opening in a top surface of the housing, an electroporation chamber below the opening of the housing, wherein the electroporation chamber comprises (i) a gasket forming the shape of the electroporation chamber and defining the volume of one or more wells within the electroporation chamber, and (ii) two or more electrodes comprising an electrically conductive, non-cytotoxic metal, wherein the two or more electrodes are positioned on opposing sides of the electroporation chamber, and wherein the processing assembly further comprises two or more buses, each connected to a single electrode. The electroporation system may also include a docking station including a housing, a port in the housing configured to receive the processing assembly, a lid connected to the housing, and one or more contacts configured to connect the docking station to an electroporation system housing.
It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the invention, as claimed.
The accompanying drawings, which are incorporated in and constitute a part of this disclosure, illustrate exemplary embodiments and, together with the description, serve to explain the disclosed principles.
As discussed in further detail below, embodiments of the present disclosure may provide systems and methods for electroporation that may include processing assemblies, trays, gaskets, docking stations, racks, packaging, and vessels for delivery to an electroporation system.
Turning now to the drawings,
Lid 104 may have a hinged connection 110 to the housing 102, that allows lid 104 to move between a closed position (
The chamber 108 may be an electroporation chamber that is a six-sided volume comprising a bottom and two opposing sides formed by a gasket (e.g., gasket 130) made of silicone rubber (or similar non-cytotoxic material), two parallel opposing sides formed from an electrically conductive, non-cytotoxic material (e.g., gold coated plastic film 128), and a top lid 104, made of polycarbonate (or similar non-cytotoxic plastic), which can be moved to allow dispensing materials in solution and into the chamber prior to electroporation, and aspiration of materials in solution from the chamber after electroporation.
Housing 102 may include a left handle 122 and a right handle 124 that connect to each other to form housing 102. The left handle 122 and right handle 124 may be spaced apart by pins 125 (or other features) that may be positioned opposite each other and may connect the left handle 122 and right handle 124.
Processing assembly 100 may further include two buses 120, one wrapped around the right handle 124 and one wrapped around the left handle 122. Each bus 120 comprises a thin film of electrically conductive metal. In some embodiments, the bus 120 comprises a thin film of aluminum. Processing assembly 100 may further include two or more electrodes 128. The bus 120 may be joined to the electrode 128 to form an electrode-bus assembly 121. In some embodiments, the bus 120 is joined to the electrode 128 by an adhesive layer to form an electrode-bus subassembly 121. The bus 120 may be configured to form an electrical connection between the electrode 128 inside the electroporation chamber, and the contacts in the electroporation instrument.
Processing assembly 100 may further include two or more electrodes 128 comprising an electrically conductive, non-cytotoxic metal, one to be received on the left handle 122 and the other on the right handle 124. In some embodiments, the electrically conductive, non-cytotoxic metal is aluminum, titanium, or gold. In some embodiments, the electrically conductive, non-cytotoxic metal is gold. Electrode 128 may comprise gold vacuum deposited on large rolls of plastic film that can be die cut to size and to be installed on processing assembly 100. Processing assembly 100 may include two electrodes 128 that are comprised of gold that is vacuum deposited onto a thin plastic film. The electrodes 128 may be evenly spaced apart across the chamber 108 and arranged parallel to the opposing electrode.
Processing assembly 100 may include a gasket 130 and plastic spacer that may be received in chamber 108. The gasket 130 forms in part the chamber 108 shape and determines the volume of the well(s). The gasket 130 forms liquid-tight seals of the well, and the gasket 130 may form multiple wells. The spacer may be a non-electrically conductive element that supports the shape of the gasket, maintains the distance between the electrodes 128, and maintains the parallelism of the electrodes 128. The gasket 130 may take at least one of several shapes and sizes as described in more detail below. For example, gasket 130 may be sized to receive samples of a variety of sizes including samples sized at 1000 μL, 400 μL, 100 μL, 100 μL×2, 50 μL×3, 50 μL×8, and 25 μL×3 variants, among others. In some embodiments, gasket 130 may be made of silicone rubber or other flexible materials. Processing assembly 100 may be configured for use with any one of the gasket sizes and arrangements described herein such that the processing assembly 100 may be used for any number of sized gaskets 130.
Processing assembly 100 may further include a device label 140 that extends around housing 102 away from buses 120. In some embodiments, device labels 140 may include a unique product serial number, size, instructions, logos, etc. Some embodiments may also provide for writing space 141 on an end of processing assembly 100.
Processing assembly 100 may provide several advantages including an increased volume range of samples within chamber 108 and gasket 130, an improved ease of use, and improvements in cell recovery and consistent performance. In some embodiments, gold coated plastic film 128 may provide a manufacturing cost reduction, and may allow for reaction volumes of 25-1000 microliters using a variety of gaskets.
Tray 160 may include one or more positions for receiving processing assemblies. In some embodiments, the tray 160 may include one or more positions 164 such that the first position and second position may allow a user to distinguish a state (e.g., complete vs. incomplete, tested vs. untested, distinguish between sample type) of the processing assembly placed in tray 160. Trays 160 may have legs 166 that may allow one or more trays 160 to be stacked on top of each other while providing clearance for the processing assemblies loaded into the tray.
Trays 160 may provide for improvements in the transportability and organization of processing assemblies and may allow for sterilization of an array of processing assemblies at once.
In other embodiments, the bottom surface may be flat instead of sloped.
In some embodiments, the gaskets may provide flexibility, and allow the use of a single or multi-well configuration to optimize workflow. Gaskets may also provide scalability and reduced dead volume by seamlessly shifting between small and large scale volumes on a single platform. Gaskets may also provide improved functionality where functional design maintains sterility while providing ease of use.
Multi-well processing assembly 200 may include a housing 202 with a lid 204 that extends along the length of the housing and covers an opening 206 to a chamber 208. In some embodiments, chamber 208 may receive samples, cultures, liquid media, etc., that may be provided to an electroporation system or device that processing assembly 200 may be compatible with.
Lid 204 may have a hinged connection 210 to one side of the housing 202, that allows lid 204 to move between a closed position (
As shown in
Processing assembly 200 may further include two or more electrodes 228 comprising an electrically conductive, non-cytotoxic metal, where one electrode is received on the left handle 222 and the other is received on the right handle 224. In some embodiments, the electrically conductive, non-cytotoxic metal is aluminum, titanium, or gold. In some embodiments, the electrically conductive, non-cytotoxic metal is gold. Electrode 228 may have gold vacuum deposited on large rolls of plastic film that can be die cut to size and for installation on processing assembly 200.
Processing assembly 200 may further include two buses 220, one wrapped around the right handle 224 and one wrapped around the left handle 222. Each bus 220 comprises a thin film of electrically conductive metal. In some embodiments, the bus 220 comprises a thin film of aluminum. The bus 220 forms an electrical connection between the electrode 228 inside the electroporation chamber, and the contacts in the electroporation instrument.
In some embodiments, the electrode 228 is joined to the bus 220 to form an electrode-bus subassembly 221. In some embodiments, the electrode 228 is joined to the bus 220 by an adhesive layer to form an electrode-bus subassembly 221. The processing assembly shown in
Processing assembly 200 may include a gasket 170 and spacer that may be received in chamber 208. The gasket 170 forms the chamber 208 shape and determines the volume of the well(s). The gasket 170 forms the liquid-tight seals of the well, and the gasket 170 may form multiple wells. The spacer may be a non-electrically conductive element that supports the shape of the gasket, maintains the distance between the electrodes 228, and maintains the parallelism of the electrodes 228. The gasket 170 may take at least one of several shapes. For example, gasket 170 may have eight wells 172 which may be sized for samples of 50 μL in each well 172. In some embodiments, gasket 170 may be made of silicone rubber or other non-cytotoxic materials. Processing assembly 200 may be configured for use with any gasket size and arrangements described herein such that the processing assembly 200 may be used for any number of sized gaskets 170.
FIGS and 40-42 illustrate outer packaging for research (RUO) and for GMP products.
Bag 460 may include a narrower inner chamber having angled lower surfaces 462, one of the lower surfaces 462 may include one or more connectors 464 and the bag 460 may also include a centrally positioned outlet 466.
Bag 470 may include a wide upper chamber 472 and a narrow lower chamber 474, the lower chamber 474 may include connectors 476 at each angled bottom surface and a centrally positioned outlet 478.
Bags 450, 460, 470 may include Luer fittings, Luer-activated ports, tubing, tube clamps and labels (see diagram in
It should be noted that the products and/or processes disclosed may be used in combination or separately. Additionally, exemplary embodiments are described with reference to the accompanying drawings. Wherever convenient, the same reference numbers are used throughout the drawings to refer to the same or like parts. While examples and features of disclosed principles are described herein, modifications, adaptations, and other implementations are possible without departing from the spirit and scope of the disclosed embodiments. It is intended that the prior detailed description be considered as exemplary only, with the true scope and spirit being indicated by the following claims.
The products and/or processes disclosed herein may be used in any application in which electroporation may be useful. Exemplary applications include assay development (such as, e.g., by co-expressing reporter and target proteins in varying ratios, and/or varying subunit ratios), developing animal models of disease, identifying and characterizing potential biomarkers, developing cell-based disease models, assessing the efficacy of pharmacological tool compounds, functional analysis of proteins of interest, in vitro and in vivo genetic manipulation, characterizing disease associated genetics, antibody discovery (such as, e.g., varying heavy/light chain ratios, and/or testing sequence variants), protein antigen and derivative expression (such as, e.g., testing sequence variants, and/or optimizing expression plasmids), gene knockdown (such as, e.g., testing various siRNA sequences and/or concentrations), and developing cell-based assays (such as, e.g., varying report/target ratios and/or relative subunit ratios), and developing therapeutics (such as, e.g., by testing sequence variants of secreted proteins, receptors and other biologics, and optimizing transposon: transposase ratios for non-vial integration of transgenes).
In some embodiments, the geometry of an electroporation chamber may be adjusted to adjust electric field strength. Field strength is calculated using voltage divided by gap size. The geometry of an electroporation chamber can be a function of the distance between electrodes, or “gap size.” Thus, in some embodiments, gap size of electrodes within an electroporation chamber may be controlled to adjust the electric field strength. By increasing the gap size, field strength can be increased without changing voltage. To derive the voltage needed to accomplish electroporation if the desired field strength and gap size are known, field strength (kV) is multiplied by gap size (cm). Electrodes of electroporation chambers can comprise two or more “plate” electrodes. The electrode plate can be addressable with an electric pulse as determined by the present disclosure. The electrodes can comprise an array of between 1 and 100 cathodes and 1 and 100 anodes, there being an even number of cathodes and anodes so as to form pairs of positive and negative electrodes. The plates can comprise a width dimension that is generally greater than the distance, or gap, between opposing electrodes, or greater than twice the gap distance.
The cathode and anode electrodes can be spaced on opposing interior sides of an electroporation chamber such that the electroporation chamber comprises an electrode gap size of at most or at least about 0.001 cm to 10 cm, 0.001 cm to 1 cm, 0.01 cm to 10 cm, 0.01 cm to 1 cm, 0.1 cm to 10 cm, 0.1 cm to 1 cm, 1 cm to 10 cm, or any value from 0.001 cm to 10 cm or range derivable therein. In some embodiments, the electroporation chamber comprises an electrode gap between 0.001 cm and 10 cm, 0.001 cm and 1 cm, 0.01 cm and 10 cm, 0.01 cm and 1 cm, 0.1 cm and 10 cm, 0.1 cm and 1 cm, 1 cm and 10 cm, or any value from 0.001 cm to 10 cm or range derivable therein. In some embodiments, the electroporation chamber comprises an electrode gap between 0.01 cm and 1 cm, any value from 0.01 cm to 1 cm, or any range derivable therein. In some embodiments, the electroporation chamber comprises an electrode gap between 0.4 cm and 1 cm, any value from 0.4 cm to 1 cm, or any range derivable therein. Each pair of said anodes and cathodes can be energized at a load resistance (in Ohms) depending upon the chamber size.
The examples presented herein are for purposes of illustration, and not limitation. Further, the boundaries of the functional building blocks have been arbitrarily defined herein for the convenience of the description. Alternative boundaries can be defined so long as the specified functions and relationships thereof are appropriately performed. Alternatives (including equivalents, extensions, variations, deviations, etc., of those described herein) will be apparent to persons skilled in the relevant art(s) based on the teachings contained herein. Such alternatives fall within the scope and spirit of the disclosed embodiments. Also, the words “comprising,” “having,” “containing,” and “including,” and other similar forms are intended to be equivalent in meaning and be open ended in that an item or items following any one of these words is not meant to be an exhaustive listing of such item or items, or meant to be limited to only the listed item or items. It must also be noted that as used herein and in the appended claims, the singular forms “a,” “an,” and “the” include plural references unless the context clearly dictates otherwise.
This application claims priority to U.S. Provisional Application No. 63/023,093, filed May 11, 2020, titled, “SYSTEMS AND METHODS FOR ELECTROPORATION,” which is incorporated herein by reference in its entirety.
Number | Date | Country | |
---|---|---|---|
63023093 | May 2020 | US |